Insider: Swayze Eric EVP Research - IONIS PHARMACEUTICALS INC
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 32,105 | 318 | 32,423 |
| Value | $2,401,132.95 | $23,783.22 | $2,424,916.17 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 02/13/2026 | DDS | 6,207 | Direct | COM | $82.07 | $509,402.90 | 32,105 |
| 02/13/2026 | DDS | 9,435 | Direct | COM | $81.56 | $769,511.05 | 38,312 |
| 01/30/2026 | DDS | 6,179 | Direct | COM | $82.93 | $512,446.10 | 47,747 |
| 01/16/2026 | DDS | 9,884 | Direct | COM | $75.34 | $744,660.56 | 41,935 |
| 01/16/2026 | DDS | 49 | Indirect | COM | $75.97 | $3,722.53 | 318 |
| 01/02/2026 | DDS | 5,125 | Direct | COM | $78.57 | $402,671.25 | 30,453 |
| 01/02/2026 | DDS | 18,338 | Direct | COM | $79.27 | $1,453,653.26 | 30,453 |
| 10/16/2025 | DDS | 53 | Indirect | COM | $73.62 | $3,901.93 | 256 |
| 10/06/2025 | DDS | 6,849 | Direct | COM | $69.02 | $472,717.98 | 30,453 |
| 10/02/2025 | DDS | 12,972 | Direct | COM | $66.23 | $859,082.37 | 37,302 |
| 10/01/2025 | DDS | 14,142 | Direct | COM | $66.09 | $934,661.75 | 37,302 |
| 09/02/2025 | DDS | 10,000 | Direct | COM | $49.22 | $492,200.00 | 38,432 |
| 09/02/2025 | DDS | 1,130 | Direct | COM | $53.68 | $60,661.68 | 37,302 |
| 01/31/2025 | DDS | 1,367 | Direct | COM | $32.31 | $44,162.03 | 48,017 |
| 01/16/2025 | DDS | 7,154 | Direct | COM | $32.84 | $234,958.82 | 45,670 |
| 01/16/2025 | DDS | 22 | Indirect | COM | $32.70 | $719.40 | 184 |
| 11/12/2024 | DDS | 1,194 | Direct | COM | $37.92 | $45,277.67 | 33,713 |
| 10/16/2024 | DDS | 53 | Indirect | COM | $38.31 | $2,030.59 | 157 |
| 02/02/2024 | DDS | 1,907 | Direct | COM | $49.56 | $94,513.40 | 34,324 |
| 01/31/2024 | DDS | 10,773 | Direct | COM | $52.00 | $560,196.00 | 32,516 |
| 01/17/2024 | DDS | 6,296 | Direct | COM | $50.42 | $317,425.43 | 43,289 |
| 01/17/2024 | DDS | 9 | Indirect | COM | $50.42 | $453.75 | 85 |
| 10/17/2023 | DDS | 52 | Indirect | COM | $47.95 | $2,493.35 | 73 |
| 02/06/2023 | DDS | 1,815 | Direct | COM | $40.79 | $74,031.31 | 31,941 |
| 01/18/2023 | DDS | 5,631 | Direct | COM | $39.74 | $223,799.59 | 30,041 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research